These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 18203317)

  • 21. TCRBV20S1 and TCRBV3S1 gene segment polymorphisms in systemic sclerosis.
    Bredemeier M; Chies JA; Wieck A; Capobianco KG; Pitrez EH; Rohde LE; Pinotti AF; Brenol JC; Xavier RM
    J Rheumatol; 2008 Jun; 35(6):1058-63. PubMed ID: 18412309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microsatellites and intragenic polymorphisms of transforming growth factor beta and platelet-derived growth factor and their receptor genes in Native Americans with systemic sclerosis (scleroderma): a preliminary analysis showing no genetic association.
    Zhou X; Tan FK; Stivers DN; Arnett FC
    Arthritis Rheum; 2000 May; 43(5):1068-73. PubMed ID: 10817561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-nucleotide polymorphisms in the SPARC gene are not associated with susceptibility to scleroderma.
    Lagan AL; Pantelidis P; Renzoni EA; Fonseca C; Beirne P; Taegtmeyer AB; Denton CP; Black CM; Wells AU; du Bois RM; Welsh KI
    Rheumatology (Oxford); 2005 Feb; 44(2):197-201. PubMed ID: 15546965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of a functional CD19 polymorphism with susceptibility to systemic sclerosis.
    Tsuchiya N; Kuroki K; Fujimoto M; Murakami Y; Tedder TF; Tokunaga K; Takehara K; Sato S
    Arthritis Rheum; 2004 Dec; 50(12):4002-7. PubMed ID: 15593213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelin axis polymorphisms in patients with scleroderma.
    Fonseca C; Renzoni E; Sestini P; Pantelidis P; Lagan A; Bunn C; McHugh N; Welsh KI; Du Bois RM; Denton CP; Black C; Abraham D
    Arthritis Rheum; 2006 Sep; 54(9):3034-42. PubMed ID: 16947775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No evidence of association between functional polymorphisms located within IL6R and IL6ST genes and systemic sclerosis.
    Cénit MC; Simeón CP; Fonollosa V; Espinosa G; Beltrán E; Sáez-Comet L; Vicente-Rabaneda E; García-Hernández FJ; Martínez-Estupiñán L; Rodríguez-Carballeira M; Hernández V; de la Peña PG; Fernández-Castro M; Narváez FJ; Pros A; Gallego M; Ríos-Fernández R; Camps MT; Fernández-Nebro A; Egurbide MV; Carreira P; González-Gay MA; Martín J;
    Tissue Antigens; 2012 Sep; 80(3):254-8. PubMed ID: 22742541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of TIMP-1 +372 SNP with digital ulcer manifestation in female systemic sclerosis patients.
    Skarmoutsou E; D'Amico F; Marchini M; Malaponte G; Scorza R; Mazzarino MC
    Hum Immunol; 2012 Sep; 73(9):950-3. PubMed ID: 22820628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic polymorphisms in the surfactant proteins in systemic sclerosis in Japanese: T/T genotype at 1580 C/T (Thr131Ile) in the SP-B gene reduces the risk of interstitial lung disease.
    Sumita Y; Sugiura T; Kawaguchi Y; Baba S; Soejima M; Murakawa Y; Hara M; Kamatani N
    Rheumatology (Oxford); 2008 Mar; 47(3):289-91. PubMed ID: 18263595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased levels of transforming growth factor beta receptor type I and up-regulation of matrix gene program: A model of scleroderma.
    Pannu J; Gardner H; Shearstone JR; Smith E; Trojanowska M
    Arthritis Rheum; 2006 Sep; 54(9):3011-21. PubMed ID: 16947635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiogenesis in systemic sclerosis: impaired expression of vascular endothelial growth factor receptor 1 in endothelial progenitor-derived cells under hypoxic conditions.
    Avouac J; Wipff J; Goldman O; Ruiz B; Couraud PO; Chiocchia G; Kahan A; Boileau C; Uzan G; Allanore Y
    Arthritis Rheum; 2008 Nov; 58(11):3550-61. PubMed ID: 18975312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphisms in the interleukin 4, interleukin 13, and corresponding receptor genes are not associated with systemic sclerosis and do not influence gene expression.
    Broen JC; Dieude P; Vonk MC; Beretta L; Carmona FD; Herrick A; Worthington J; Hunzelmann N; Riemekasten G; Kiener H; Scorza R; Simeon CP; Fonollosa V; ; Carreira P; Ortego-Centeno N; Gonzalez-Gay MA; Airo' P; Coenen MJ; Tsang K; Aliprantis AO; Martin J; Allanore Y; Radstake TR
    J Rheumatol; 2012 Jan; 39(1):112-8. PubMed ID: 22045834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis.
    Manetti M; Allanore Y; Revillod L; Fatini C; Guiducci S; Cuomo G; Bonino C; Riccieri V; Bazzichi L; Liakouli V; Cipriani P; Giacomelli R; Abbate R; Bombardieri S; Valesini G; Montecucco C; Valentini G; Ibba-Manneschi L; Matucci-Cerinic M
    Arthritis Rheum; 2011 Jan; 63(1):247-56. PubMed ID: 20967855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. -238 and +489 TNF-alpha along with TNF-RII gene polymorphisms associate with the diffuse phenotype in patients with Systemic Sclerosis.
    Tolusso B; Fabris M; Caporali R; Cuomo G; Isola M; Soldano F; Montecucco C; Valentini G; Ferraccioli G
    Immunol Lett; 2005 Jan; 96(1):103-8. PubMed ID: 15585313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemorheologic profile in systemic sclerosis: role of NOS3 -786T > C and 894G >T polymorphisms in modulating both the hemorheologic parameters and the susceptibility to the disease.
    Fatini C; Mannini L; Sticchi E; Rogai V; Guiducci S; Conforti ML; Cinelli M; Pignone AM; Bolli P; Abbate R; Cerinic MM
    Arthritis Rheum; 2006 Jul; 54(7):2263-70. PubMed ID: 16802365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular damage and lack of angiogenesis in systemic sclerosis skin.
    Konttinen YT; Mackiewicz Z; Ruuttila P; Ceponis A; Sukura A; Povilenaite D; Hukkanen M; Virtanen I
    Clin Rheumatol; 2003 Sep; 22(3):196-202. PubMed ID: 14505210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of association of eNOS (G894T) and p22phox NADPH oxidase subunit (C242T) polymorphisms with systemic sclerosis in a cohort of French Caucasian patients.
    Allanore Y; Borderie D; Lemaréchal H; Ekindjian OG; Kahan A
    Clin Chim Acta; 2004 Dec; 350(1-2):51-5. PubMed ID: 15530459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-nucleotide polymorphisms in the IL-4 and IL-13 promoter region in aggressive periodontitis.
    Gonzales JR; Mann M; Stelzig J; Bödeker RH; Meyle J
    J Clin Periodontol; 2007 Jun; 34(6):473-9. PubMed ID: 17451413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of the association between Rho/Rho-kinase gene polymorphisms and systemic sclerosis.
    Pehlivan Y; Yolbas S; Cetin GY; Alibaz-Oner F; Cagatay Y; Yilmaz N; Oztuzcu S; Donmez S; Ozgen M; Koca SS; Pamuk ON; Sayarlıoglu M; Kisacik B; Direskeneli H; Demiryurek AT; Onat AM
    Rheumatol Int; 2016 Mar; 36(3):421-7. PubMed ID: 26615410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin-converting enzyme gene does not contribute to genetic susceptibility to systemic sclerosis in European Caucasians.
    Wipff J; Gallier G; Dieude P; Avouac J; Tiev K; Hachulla E; Granel B; Diot E; Sibilia J; Mouthon L; Meyer O; Kahan A; Varret M; Boileau C; Allanore Y
    J Rheumatol; 2009 Feb; 36(2):337-40. PubMed ID: 19132786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allograft inflammatory factor-1 and tumor necrosis factor single nucleotide polymorphisms in systemic sclerosis.
    Otieno FG; Lopez AM; Jimenez SA; Gentiletti J; Artlett CM
    Tissue Antigens; 2007 Jun; 69(6):583-91. PubMed ID: 17498268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.